MXPA02006028A - Lipopeptidos novedosos como agentes antibacterianos. - Google Patents
Lipopeptidos novedosos como agentes antibacterianos.Info
- Publication number
- MXPA02006028A MXPA02006028A MXPA02006028A MXPA02006028A MXPA02006028A MX PA02006028 A MXPA02006028 A MX PA02006028A MX PA02006028 A MXPA02006028 A MX PA02006028A MX PA02006028 A MXPA02006028 A MX PA02006028A MX PA02006028 A MXPA02006028 A MX PA02006028A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- daptomycin
- analogs
- antibacterial agents
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se relaciona con compuestos lipopeptidicos novedosos. La invencion tambien se relaciona con composiciones farmaceuticas de estos compuestos y los metodos para utilizar estos compuestos como compuestos antibacterianos. La invencion tambien se relaciona con los metodos para producir estos compuestos lipopeptidicos novedosos y los intermediarios utilizados para producir estos compuestos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17094599P | 1999-12-15 | 1999-12-15 | |
PCT/US2000/034051 WO2001044271A2 (en) | 1999-12-15 | 2000-12-15 | Daptomycin analogs and their use as antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02006028A true MXPA02006028A (es) | 2004-08-23 |
Family
ID=22621920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02006028A MXPA02006028A (es) | 1999-12-15 | 2000-12-15 | Lipopeptidos novedosos como agentes antibacterianos. |
Country Status (13)
Country | Link |
---|---|
US (1) | US6794490B2 (es) |
EP (1) | EP1240182A2 (es) |
JP (1) | JP2003517003A (es) |
KR (1) | KR20020063230A (es) |
CN (1) | CN1423655A (es) |
AU (1) | AU784942B2 (es) |
BR (1) | BR0017028A (es) |
CA (1) | CA2394313A1 (es) |
IL (1) | IL150224A0 (es) |
MX (1) | MXPA02006028A (es) |
NO (1) | NO20022886L (es) |
WO (1) | WO2001044271A2 (es) |
ZA (1) | ZA200205113B (es) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7408025B2 (en) * | 1999-12-15 | 2008-08-05 | Cubist Pharmaceuticals, Inc. | Lipopeptides as antibacterial agents |
US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
CA2301336A1 (en) * | 2000-03-17 | 2001-09-17 | Michael T. Kelly | Topical treatment of rosacea |
US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
ES2377931T5 (es) | 2000-12-18 | 2015-11-04 | Cubist Pharmaceuticals, Inc. | Métodos para preparar lipopéptidos purificados |
EP1932853A1 (en) | 2001-08-06 | 2008-06-18 | Cubist Pharmaceutical Inc. | Novel depsipeptides and process for preparing same |
EP1423414A4 (en) | 2001-08-06 | 2005-11-30 | Cubist Pharm Inc | NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF |
US6767718B2 (en) | 2002-05-10 | 2004-07-27 | Biosource Pharm, Inc. | Lipodepsipeptide antibiotics and methods of preparation |
WO2003099217A2 (en) * | 2002-05-23 | 2003-12-04 | Activbiotics, Inc. | Methods of treating bacterial infections and diseases associated therewith |
US20090149453A1 (en) * | 2002-05-23 | 2009-06-11 | Activbiotics Pharma Llc | Methods and compositions for treating bacterial infections and diseases associated therewith |
US20040077533A1 (en) * | 2002-05-23 | 2004-04-22 | Sayada Chalom B. | Methods and compositions for treating bacterial infections and diseases associated therewith |
US7317001B2 (en) | 2002-06-06 | 2008-01-08 | Oscient Pharmaceuticals Corporation | Use of ramoplanin to treat diseases associated with the use of antibiotics |
IL150907A (en) * | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
US7671011B2 (en) * | 2003-06-19 | 2010-03-02 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
US20050123602A1 (en) * | 2003-09-25 | 2005-06-09 | Michaelis Arthur F. | Rifalazil formulations |
SE0303588D0 (sv) | 2003-12-30 | 2003-12-30 | Bioactive Polymers Ab C O Lund | Surface protection of exposed biological tissues |
ES2305897T3 (es) * | 2003-12-30 | 2008-11-01 | Bioactive Polymers Ab | Proteccion de superficie de tejidos biologicos expuestos. |
WO2005089236A2 (en) | 2004-03-13 | 2005-09-29 | Cluster Resources, Inc. | System and method for providing intelligent pre-staging of data in a compute environment |
US8782654B2 (en) | 2004-03-13 | 2014-07-15 | Adaptive Computing Enterprises, Inc. | Co-allocating a reservation spanning different compute resources types |
US20070266388A1 (en) | 2004-06-18 | 2007-11-15 | Cluster Resources, Inc. | System and method for providing advanced reservations in a compute environment |
US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
US8176490B1 (en) | 2004-08-20 | 2012-05-08 | Adaptive Computing Enterprises, Inc. | System and method of interfacing a workload manager and scheduler with an identity manager |
US8271980B2 (en) | 2004-11-08 | 2012-09-18 | Adaptive Computing Enterprises, Inc. | System and method of providing system jobs within a compute environment |
CA2587848A1 (en) * | 2004-11-12 | 2006-10-19 | Cubist Pharmaceuticals, Inc. | Antiinfective lipopeptides |
US20080051326A1 (en) * | 2004-11-12 | 2008-02-28 | Alexander Dylan C | Antiinfective Lipopeptides |
US20080171766A1 (en) * | 2005-03-10 | 2008-07-17 | Smithkline Beecham Corporation | Novel Method |
US8863143B2 (en) | 2006-03-16 | 2014-10-14 | Adaptive Computing Enterprises, Inc. | System and method for managing a hybrid compute environment |
US9231886B2 (en) | 2005-03-16 | 2016-01-05 | Adaptive Computing Enterprises, Inc. | Simple integration of an on-demand compute environment |
ES2614751T3 (es) | 2005-04-07 | 2017-06-01 | Iii Holdings 12, Llc | Acceso bajo demanda a recursos informáticos |
US8968781B2 (en) * | 2005-04-29 | 2015-03-03 | Cubist Pharmaceuticals, Inc. | Therapeutic compositions |
EP2018864A1 (en) | 2007-07-23 | 2009-01-28 | Biomet Deutschland GmbH | Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition |
US8041773B2 (en) | 2007-09-24 | 2011-10-18 | The Research Foundation Of State University Of New York | Automatic clustering for self-organizing grids |
PT2379580E (pt) * | 2008-12-22 | 2014-01-20 | Cubist Pharm Inc | Novos agentes antibacterianos para o tratamento de infecções por bactérias gram positivas |
TW201035111A (en) | 2008-12-23 | 2010-10-01 | Biosource Pharm Inc | Antibiotic compositions for the treatment of gram negative infections |
US11720290B2 (en) | 2009-10-30 | 2023-08-08 | Iii Holdings 2, Llc | Memcached server functionality in a cluster of data processing nodes |
US10877695B2 (en) | 2009-10-30 | 2020-12-29 | Iii Holdings 2, Llc | Memcached server functionality in a cluster of data processing nodes |
US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
WO2012011917A1 (en) * | 2010-07-23 | 2012-01-26 | Activbiotics Pharma, Llc | Administration of rifalazil to immunocompromised patients |
KR20140037877A (ko) * | 2011-05-26 | 2014-03-27 | 큐비스트 파마슈티컬즈 인코포레이티드 | Cb-183,315 조성물 및 관련 방법 |
WO2013039861A2 (en) | 2011-09-12 | 2013-03-21 | modeRNA Therapeutics | Engineered nucleic acids and methods of use thereof |
WO2013059610A1 (en) | 2011-10-20 | 2013-04-25 | Trius Therapeutics, Inc. | Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use |
EP2833892A4 (en) | 2012-04-02 | 2016-07-20 | Moderna Therapeutics Inc | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY |
WO2013151666A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of biologics and proteins associated with human disease |
WO2017083515A2 (en) | 2015-11-10 | 2017-05-18 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
US10358463B2 (en) * | 2016-04-05 | 2019-07-23 | Bristol-Myers Squibb Company | Immunomodulators |
US11890319B2 (en) | 2017-01-18 | 2024-02-06 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
KR20200020858A (ko) * | 2017-06-23 | 2020-02-26 | 브리스톨-마이어스 스큅 컴퍼니 | Pd-1의 길항제로서 작용하는 면역조정제 |
CN116710146A (zh) | 2020-04-03 | 2023-09-05 | 威特拉公司 | 抗体分子-药物偶联物及其用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32310E (en) | 1982-05-21 | 1986-12-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
US4524135A (en) | 1982-05-21 | 1985-06-18 | Eli Lilly And Company | A-21978C cyclic peptides |
US4537717A (en) | 1982-05-21 | 1985-08-27 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
US4399067A (en) | 1982-05-21 | 1983-08-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
USRE32311E (en) | 1982-05-21 | 1986-12-16 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
IL68700A0 (en) * | 1982-05-21 | 1983-09-30 | Lilly Co Eli | Improvements relating to a-21978c cyclic peptide derivatives and their production |
US4396543A (en) | 1982-05-21 | 1983-08-02 | Eli Lilly And Company | Derivatives of A-21978C cyclic peptides |
US4482487A (en) | 1982-05-21 | 1984-11-13 | Eli Lilly And Company | A-21978C cyclic peptides |
CA1315229C (en) | 1987-06-10 | 1993-03-30 | Patrick J. Baker | Chromatographic purification process |
EP0460882B1 (en) | 1990-06-07 | 1996-07-24 | Eli Lilly And Company | Lipopeptide deacylase |
DE4411025A1 (de) | 1994-03-30 | 1995-10-05 | Hoechst Ag | Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
KR100545506B1 (ko) | 1996-03-08 | 2006-10-04 | 아스테라스 세이야쿠 가부시키가이샤 | 환상 리포펩티드 물질의 탈아실화 방법 |
DE19807972A1 (de) | 1998-02-25 | 1999-08-26 | Hoechst Marion Roussel De Gmbh | Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung |
-
2000
- 2000-12-15 AU AU32640/01A patent/AU784942B2/en not_active Ceased
- 2000-12-15 CN CN00818393A patent/CN1423655A/zh active Pending
- 2000-12-15 MX MXPA02006028A patent/MXPA02006028A/es not_active Application Discontinuation
- 2000-12-15 CA CA002394313A patent/CA2394313A1/en not_active Abandoned
- 2000-12-15 BR BR0017028-3A patent/BR0017028A/pt not_active IP Right Cessation
- 2000-12-15 EP EP00991409A patent/EP1240182A2/en not_active Withdrawn
- 2000-12-15 WO PCT/US2000/034051 patent/WO2001044271A2/en active IP Right Grant
- 2000-12-15 US US09/739,535 patent/US6794490B2/en not_active Expired - Lifetime
- 2000-12-15 JP JP2001544760A patent/JP2003517003A/ja not_active Withdrawn
- 2000-12-15 KR KR1020027007688A patent/KR20020063230A/ko not_active Application Discontinuation
- 2000-12-15 IL IL15022400A patent/IL150224A0/xx unknown
-
2002
- 2002-06-17 NO NO20022886A patent/NO20022886L/no not_active Application Discontinuation
- 2002-06-25 ZA ZA200205113A patent/ZA200205113B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200205113B (en) | 2003-11-26 |
NO20022886D0 (no) | 2002-06-17 |
KR20020063230A (ko) | 2002-08-01 |
AU3264001A (en) | 2001-06-25 |
WO2001044271A2 (en) | 2001-06-21 |
EP1240182A2 (en) | 2002-09-18 |
CA2394313A1 (en) | 2001-06-21 |
NO20022886L (no) | 2002-08-02 |
WO2001044271A3 (en) | 2002-03-07 |
JP2003517003A (ja) | 2003-05-20 |
IL150224A0 (en) | 2002-12-01 |
BR0017028A (pt) | 2003-01-07 |
US20020058785A1 (en) | 2002-05-16 |
CN1423655A (zh) | 2003-06-11 |
AU784942B2 (en) | 2006-08-03 |
US6794490B2 (en) | 2004-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02006028A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
MXPA02006029A (es) | Lipopeptidos novedosos como agentes antibacterianos. | |
MXPA02006030A (es) | Lipopeptidos como agentes antibacterianos. | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
EE200100485A (et) | Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena | |
AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
EP1423414A4 (en) | NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF | |
IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
MXPA05009682A (es) | Metodos de radiofluorinacion de vectores biologicamente activos. | |
AU8490901A (en) | Urea compounds and methods of uses | |
PL358281A1 (en) | Novel compounds | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
SE9901077D0 (sv) | Novel use | |
YU79202A (sh) | Peptid koji modulira trombopoetinski receptor | |
RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
MXPA04001773A (es) | Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos. | |
MXPA03000606A (es) | Derivados de benzofurano y su uso como agentes antibacterianos. | |
MY140724A (en) | Novel arylethene-sulfonamides | |
PL328225A1 (en) | Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors | |
WO2006110185A3 (en) | Antiinfective lipopeptides | |
MX9706927A (es) | Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas. | |
MY138502A (en) | Novel alkansulfonamides as endothelin antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |